![]() |
|
|
Vol. 280, Issue 2, 1038-1042, 1997
Department of Pathology (S.M.H.S., A.A.N.), Beth Israel Deaconess
Medical Center and Harvard Medical, Boston, Massachusetts and
Biomedical Frontiers Inc. (P.E.H.) Minneapolis, Minnesota
We studied the effect of the long-acting parenteral iron chelator,
hydroxyethyl starch deferoxamine (HES-DFO) on liver nonheme iron, lipid
peroxidation and pathologic changes in the liver in the intragastric
feeding rat model for alcoholic liver disease. Male Wistar rats
(225-250 g) were fed liquid diet and ethanol for 2 months. In control
pair-fed animals, ethanol was isocalorically replaced by dextrose. Two
additional groups of animals (dextrose and ethanol fed) received
HES-DFO (25 mg deferoxamine equivalents/kg, three times a week). The
blood ethanol level in the ethanol-fed animals was maintained between
150 and 350 mg/dl. For each animal, the levels of hepatic nonheme iron,
lipid peroxidation and pathologic changes were evaluated. Ethanol
administration caused fatty liver, necrosis and inflammation. Addition
of HES-DFO to the ethanol diet increased the severity of pathologic
changes, particularly necrosis and inflammation. The nonheme iron in
alcohol-fed animals was significantly higher (18.3 ± 4.3 µg
liver) than in pair-fed dextrose controls (12.5 ± 1.5 µg,
P < .05). Addition of HES-DFO significantly increased nonheme
iron levels in the dextrose-fed rats (17.1 ± 2.0 µg/g, P < .02) but not in ethanol-fed rats (20.0 ± 2.0). Ethanol
increased levels of conjugated dienes; these levels were not altered by
HES-DFO. The most significant observations in this study were: 1) the
higher hepatic nonheme iron content in ethanol-fed rats compared with
pair-fed dextrose controls; 2) the absence of changes in hepatic
nonheme iron levels or lipid peroxidation in ethanol-fed groups treated
with HES-DFO; and 3) the worsening of liver injury in ethanol-fed rats
by HES-DFO.